Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574678 · ClinicalTrials.gov registry record · Phase 1
Analyzing the Composition of Tears to Identify Cancer
A Phase 1 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
NCT00574678 is a Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 150 participants.
The verdict
NCT00574678, a Phase 1 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.
Interventions
- OTHER Tear collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2006-12 |
| Est. Completion | 2016-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574678
The ClinicalTrials.gov registry entry for NCT00574678 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tear collection is the first listed.
NCT00574678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574678 about?
NCT00574678 is a clinical study titled "Analyzing the Composition of Tears to Identify Cancer". This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.
What is the current status of trial NCT00574678?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2006-12. Estimated completion is 2016-02.
What interventions are being tested in trial NCT00574678?
The interventions under investigation include: Tear collection (OTHER).
Who is sponsoring clinical trial NCT00574678?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.